Prelude Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,800
| Closed | -$553K | – | 1039 |
|
|
2025
Q1 | $553K | Buy |
+22,800
| New | +$553K | 0.04% | 410 |
|
|
2024
Q4 | – | Sell |
-12,325
| Closed | -$245K | – | 1138 |
|
|
2024
Q3 | $245K | Sell |
12,325
-10,525
| -46% | -$209K | 0.01% | 877 |
|
|
2024
Q2 | $354K | Sell |
22,850
-3,049
| -12% | -$47.2K | 0.02% | 639 |
|
|
2024
Q1 | $413K | Sell |
25,899
-26,408
| -50% | -$421K | 0.02% | 638 |
|
|
2023
Q4 | $879K | Buy |
52,307
+38,303
| +274% | +$644K | 0.06% | 271 |
|
|
2023
Q3 | $164K | Buy |
+14,004
| New | +$164K | 0.01% | 804 |
|
|
2019
Q3 | – | Sell |
-23,270
| Closed | -$89K | – | 1250 |
|
|
2019
Q2 | $89K | Buy |
+23,270
| New | +$89K | ﹤0.01% | 668 |
|
|
2017
Q4 | – | Sell |
-270
| Closed | -$1K | – | 1267 |
|
|
2017
Q3 | $1K | Sell |
270
-540
| -67% | -$2K | ﹤0.01% | 1434 |
|
|
2017
Q2 | $2K | Buy |
+810
| New | +$2K | ﹤0.01% | 1398 |
|